Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD7-CART01 in Pediatric Relapsed/Refractory T-ALL/T-LL
NCT06064903Phase 2Recruiting
- Start
- Apr 2024
- Primary completion
- Sep 2028
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD7-CART01 in t-cell acute lymphoblastic leukemia (T-ALL), lymphoblastic lymphoma (LL). Started Apr 2024; status: recruiting.
02
Drugs
CD7-CART01
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT06064903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06064903.